<DOC>
	<DOCNO>NCT01607190</DOCNO>
	<brief_summary>The purpose study validate predictive model diabetic retinopathy progression patient diabetes mellitus type 2 patient clinically significant macular edema ( CSME ) need treatment either photocoagulation intravitreal injection ( ITV ) use non-invasive technique .</brief_summary>
	<brief_title>Biomarkers Diabetic Retinopathy Progression</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Type 2 diabetes mellitus Age 35 yearsold Nonproliferative diabetic retinopathy ( Levels 20 35 , accord ETDRS criterion ) Best Corrected Visual Acuity &gt; 20/25 ETDRS chart Informed Consent Previous laser therapy Other retinal vascular disease Glaucoma Recent intraocular surgery ( last 6 month ) Inadequate ocular medium and/ pupil dilatation permit good quality fundus photography ( e.g . cataract ) HbA1C &gt; 11 % Screening Subject condition situation may put him/her significant risk , may confound study result may interfere significantly his/ participation study .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>nonproliferative diabetic retinopathy</keyword>
</DOC>